Company / Current Liabilities per Share
Arbutus Biopharma Corp Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.03
FY2025
5-year range
$0.03 / $0.23
FY2021-FY2025
Trend
-65.6%
vs FY2024
Sector context
#209 of 210
Health Care
What the data says
Among 210 Health Care companies, Arbutus Biopharma Corp is in the top 0% for current liabilities per share. Current Liabilities per Share has declined for 3 consecutive years, from $0.23 in FY2022 to $0.03 in FY2025.
Based on SEC 10-K filings.
0.03 in FY2025 with a 5-year CAGR of -26.5%.
Improved from $0.14 to $0.03 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -48.1%
- 5-Year CAGR
- -26.5%
- 10-Year CAGR
- -
Sector benchmark
Top 0% in Health CareTop 0% of 210This company $0.03 Sector average $23.79
▼
-99.9% below sector average
Key checks
Key Insights
- Arbutus Biopharma Corp's current liabilities per share has declined for 3 consecutive years.
- In FY2025, current liabilities per share decreased 65.6% year-over-year.
- Ranks #209 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.03 | -65.6% |
| FY2024 | $0.09 | -35.6% |
| FY2023 | $0.14 | -37.0% |
| FY2022 | $0.23 | +81.1% |
| FY2021 | $0.13 | -15.0% |
| FY2020 | $0.15 | +4.5% |
| FY2019 | $0.14 | -30.9% |
| FY2018 | $0.20 | -23.2% |
| FY2017 | $0.27 | +37.6% |
| FY2016 | $0.19 | -0.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026